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Abstract
Implant ruptures may be diagnosed by physical examination, ultrasound (US), and magnetic resonance imaging (MRI). The absence
of standard guidelines to approach to implant ruptures may cause unnecessary surgical revisions in the absence of radiological
confirmation of prosthetic damages.
The purpose of this study was to analyze the diagnostic procedures applied to patients with suspected prosthetic rupture and
surgeon choices to perform a revision or to plan a clinical and radiological follow-up.
We conducted a retrospective study on 62 women submitted to revision surgery due to radiological diagnosis of suspected
implant rupture, following mastectomy or aesthetic reconstruction, and admitted to a Plastic Surgery Department between 2008 and
2018.
Seventy-three implants, believed to be ruptured, were explanted. One-third of these were intact and unnecessarily explanted. US
associated with MRI evaluation resulted in the most helpful diagnostical method.
A standardized clinical and radiological approach is essential to manage breast implant ruptures successfully. An innovative
protocol is proposed in order to: ensure the appropriate management of implant ruptures and prevent unnecessary surgical
revisions; reduce the risk of claims for medical malpractice in cases of unsatisfactory final aesthetic results or worse than before.
Abbreviations: EBM= evidence-basedmedicine, FDA= Food and Drug Administration, MRI=magnetic resonance imaging, US
= ultrasound.
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Capsular contracture and implant rupture are the most frequent
postoperative complications of breast implantation.[1] Iatrogenic
damage, trauma, implant shell degradation, and mechanical
pressure during mammography are among the reported mecha-
nisms of implant rupture. Ruptures have been reported up to 15
years after implantation. [2–4]
Breast implant ruptures are often silent and patients do not
display any of the traditional symptoms such as changes in breast
shape, size or firmness, capsular contracture, palpable lumps, or
breast pain. However, if diagnosed, such complications demand
careful clinical and radiological evaluation and a sound decision-
making process in order to decide whether a prosthetic
replacement is feasible or not.[5]
Correct treatment of implant rupture is also necessary to
reduce the risk of claims for malpractice and compensation for
damage suffered by the patient.[6–10]
The diagnosis of implant rupture is dependent upon imaging
techniques such as mammography, ultrasound (US), and
magnetic resonance imaging (MRI).[11,12]
In extracapsular rupture, both the implant shell and the fibrous
capsule are breached, with macroscopic silicone leakage into the
surrounding tissues or lymph nodes. Pathognomonic signs of
extracapsular rupture are visible with both US and MRI.[11]
In intracapsular rupture, the implant shell is breached without
macroscopic silicone leakage beyond the intact fibrous capsule.
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between the fibrous capsule and the prosthetic wall, which may
show introflexion or stepladder signs while the signs revealed by
MRI include the keyhole, noose, parallel line, pince-nez, “C” and
linguine signs.[13,14]
As reported in the literature, there are fewer false positives in
the diagnosis of extracapsular rupture than intracapsular
rupture, whether US or MRI is used.[13–15]
A diagnosis of “suspected prosthetic rupture” is often possible
by means of both US and MRI; in such cases, the radiologist will
often employ only one of the 2 techniques and then advise the
patient to consult a plastic surgeon.[16]
Furthermore, a diagnosis of suspected rupture in asymptom-
atic patients may cause the patient to experience anxiety and to
complain of vague symptoms. This may in turn persuade the
surgeon to perform revision surgery, even though the symptoms
do not necessarily warrant such a course of action; in
asymptomatic cases such as these, it is preferable for the surgeon,
in agreement with the patient, to initiate a period of careful
clinical monitoring while awaiting the prosthetic revision
surgery.[7–10,17–19]
Owing to the lack of standard operative guidelines available in
the literature, the aim of this work was to analyze the diagnostic
and operative decisions made by surgeons in our University
Hospital, in cases of confirmed or suspected prosthetic rupture in
both symptomatic and asymptomatic patients, in order to
identify the most critical aspects involving the management of
such complications.
A practical protocol has been consequently designed, on the
basis of the observational evidences, aiming to:1. ensure the appropriate management of patients suffering from
such complications2. reduce the risk of demands for compensation from patients
claiming for medical malpractice particularly in cases where
the final aesthetic results are unsatisfactory or worse than
before (owing to the intrinsic difficulties of such operations)
and revision surgery reveals that there had in fact been no
rupture of the implant.
2. Materials and methods
A retrospective observational and descriptive analysis was
carried out between November 2008 and December 2018 on
62 patients who had undergone surgical removal of their
prostheses following a diagnosis of suspected rupture. The
women observed in our study had received their prostheses either
following a mastectomy or after surgery performed for purely
aesthetic reasons.
Patients who experienced both a suspected implant rupture
and a recurrence of breast cancer were excluded from our study
because in these cases radiological imaging cannot provide a
clear, unambiguous diagnosis of prosthetic rupture.
Reported symptoms (pain, discomfort, breast deformation,
redness) and main purposes of radiological investigations
(follow-up/control, symptoms, trauma) were analyzed. The
following data were screened: physical examination at presenta-
tion, radiological and surgical data.
Structural data of all removed prostheses involving material,
texture, and Food and Drug Administration (FDA) guidances
were analyzed.[20]2
The study followed the principles of the Helsinki Declaration
and was approved by the local ethics committee.
2.1. Evaluation of implant integrity
The results of US and MRI examinations requested by surgeon
consultants were classified as follows:1. normal implantwhen the shell showed no loss of continuity or
when the typical signs of prosthetic rupture were absent2. suspected prosthetic rupture when there were changes to the
contour of the implant but no signs of rupture3. confirmed prosthetic rupture when the shell showed a loss of
continuity with the release of silicone from the implant.
The confirmed prosthetic rupture category was further
subdivided into intracapsular rupture (where the silicone
remained within the fibrous capsule), extracapsular rupture
(where the silicone leaked outside the fibrous capsule into the
surrounding breast tissue), and intraextracapsular rupture (when
both features appeared).
2.2. Findings at explantation
After removal, the implants were examined for rupture, and
classified as ruptured (intracapsular/extracapsular) or intact.
Implants were considered to be normal when the elastomeric
envelope was intact with no perforations, even when there was a
thin layer of silicone caused by gel bleed; implants in which the
elastomer shell presented a lack of continuity, peripheral fibrosis,
or exudation were classified as ruptured. As requested by the
manufacturer, the removed implants were sterilized and returned
for further examination.
Any capsule irregularities were documented and a capsular
biopsy was sent for pathological examination.3. Results
We examinated 62women (73 implants). Mean implant duration
was 11.8 years (range 8–14 years).
All the removed prostheses were silicone gel made. The shape
of removed implants was round (45% cases) and anatomical
(55% cases) while their surface was both smooth (27% cases)
and texturized (73% cases) (Table 1). The symptoms that the
patients complained of, during the first follow-up with a plastic
surgeon, were: pain and discomfort (28 cases: 45%), breast
deformation (16 cases: 26%), and redness (4 cases: 7%); 14 the
patients reported no pain (22%).
The clinical conditions necessitating radiological examination
were: control/follow-up (38 cases: 61%), the presence of
deformity-asymmetry and redness (14 cases: 22%), pain and
discomfort (8 cases: 13%), and accidental trauma to the breast (2
cases: 4%).
The radiological procedures requested by surgeons were:
ultrasound alone (40 cases: 55%), MRI alone (25 cases: 34%),
MRI as a diagnostic follow-up after ultrasound diagnosis of
suspected rupture (8 cases: 11%) (Table 2).
The radiological investigations (using US, MRI, or a
combination of both) showed: 59 cases intracapsular (81%),
11 cases extracapsular (15%), and 3 cases of intra and
extracapsular rupture (3%).
At explantation 44 (60%) implants were found to be ruptured
and 29 (40%) were intact (Table 3).
Table 1
Implant characteristics of our cases suspected of rupture.
Number of patients 62
Number of implants 73






























Number of implants with rupture at explantation 44/73 (60%)
Intracapsular rupture 32/44 (73%)
Extracapsular rupture 12/44 (27%)
Number of implants without rupture at explantation 29/73 (40%)
Ultrasound-suspected implants found intact 18/40 (45%)
Magnetic resonance imaging-suspected implants found intact 9/25 (35%)
Ultrasound+magnetic resonance imaging-suspected implants
were found intact
2/8 (25%)
Zingaretti et al. Medicine (2020) 99:27 www.md-journal.comLastly, none of the capsules sent for pathological examination
were positive for breast carcinoma or anaplastic large cell
lymphoma.4. Discussion
Breast implant rupture is one of the most serious complications
and concerns for patients.
Both manufacturers and physicians commonly notify that
breast implants are semipermanent. However, according to FDA
classifications, breast implants have a limited product-life. A
breast implant maintains its mechanical integrity for decades in a
woman’s body although the incidence of rupture increases with
time.[20]
All the breast implants evaluated in our study had a CE
(European Community) certification.
The majority of the removed prostheses (73%) were according
to all FDA guidelines for material, texture, and labelingTable 2
Evaluation of implant integrity.
Ultrasonography 40/73 (55%)
Magnetic resonance imaging 25/73 (34%)
Ultrasonography + magnetic resonance imaging 8/73 (11%)
Diagnosis of
Intracapsular rupture 59/73 (81%)
Extracapsular rupture 11/73 (15%)
Intra-extracapsular rupture 3/73 (4%)
3
recommendations (i.e., Mentor, Natrelle, Inamed Corporation,
McGhan prostheses).
Ruptures of prostheses may involve both smooth and
texturized surfaces, both saline and silicone gel structures (the
frequency of rupture is lower in case of silicone gel structure).[21]
In case of breast implants with a textured shell surface the
producer employs a patented manufacturing process to make a
specific textured surface so that all commercialized textured shells
are structurally different.
It should be also taken into account that data from literature
identified some patented prostheses having a frequency of rupture
higher than other ones in use.[22]
The brand and “texturing process” of a prosthesis does not
affect its radiological imaging and is not crucial for the clinical
approach in cases of patients with a prosthetic suspected rupture.
Breast implant ruptures can be difficult to identify due to a
frequent lack of symptoms and the different diagnostic and
operative approaches employed by radiologists and surgeons.
Furthermore, there is no standardized approach to implant
rupture, with the choice of radiological procedure (mammogra-
phy, US, orMRI) and surgical procedure varying from one Breast
Unit to another.
As reported by FDA guidelines, MRI is the most effective
method for detecting silent rupture of silicone gel-filled breast
implants.[20] On the other hand MRI evaluation is expensive, so
thatMRI scans are generally planned for symptomatic patients or
when suggestive findings are highlighted by US or mammo-
gram.[21]
In Italian context asymptomatic suspected ruptures are
diagnosed by US during normal follow-up checks and radiol-
ogists address them to MRI examination and surgical visit while
symptomatic patients or suffering trauma undergo MRI directly.
Rietjens et al reported that MRI has an overall accuracy of
94%, compared with 72% for ultrasound and stated that MRI
should be preferred when investigating possible implant rupture
in women who had undergone mastectomy.[7] Considering the
higher costs of MRI, the authors admitted that US will continue
to be used in many cases.[5,11,16]
As long as the patient is asymptomatic, yearly US examinations
are sufficient, with MRI imaging every 5 years. However, in the
case of symptomatic patients, MRI is preferable.[5,12,16]
US gives a higher percentage of false positives in asymptomatic
patients and often results in unnecessary operations and increases
the costs of screening and further surgery. MRI, on the other
hand, is more accurate and sensitive in detecting rupture and
should therefore be used for further screening if an abnormality is
found.[5,11,12]
Our experience confirms that a selective use of MRI following
US gives a lower percentage of false positives. The combination of
both techniques can increase the sensitivity of radiological
Zingaretti et al. Medicine (2020) 99:27 Medicinediagnosis and will result in fewer surgical operations and lower
overall costs.
According to published data, our study confirmed that more
than one-third of suspected implants were intact and unneces-
sarily explanted; when the prosthesis was found to be intact at
explantation, a previous incorrect diagnosis of rupture resulted as
already performed through US.[4,14]
Moreover, our experience confirms that the psychological
discomfort of the patient may influence the surgeon’s decision
about the diagnostic and therapeutic procedure to be undertaken.
It must be taken into account that near 50% of women report
symptoms during follow-up or surgical visit after a radiological
diagnosis: symptoms are often due to somatized psychological
disturbances producing pain which may induce the surgeon to
plan a prosthetic revision.MRI: magnetic resonance imaging
EBM: evidence based medicine
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Figure 1. Flowchart. Asymptomatic patients request US at follow-up. Patients w
necessary when US and MRI confirm the prosthetic rupture. An interview with s
procedure in cases of unconfirmed prosthetic rupture as follows: asymptomatic sub
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To date, there is no agreed standard diagnostic approach for
identifying patients who require prosthetic revision surgery and
clinicians, sometimes merely to avoid the risk of litigation, may
carry out unnecessary prosthetic revisions.[7–10,17–19] This can
lead to complications, because the second operation can result in
a poor aesthetic outcome.[7–10,17–19] Such situations can lead to
litigation and claims for compensation made by patients who are
not satisfied with the aesthetic and/or functional results,
especially when they learn that the implant was, in fact, intact
and that the surgery was unnecessary.[7–10,17]
We have designed a practical protocol to ensure a most
appropriate diagnosis of prosthetic rupture using a combination
of US and MRI without unnecessary revisions: an innovative
flowchart has been planned considering symptoms, US andMRI,























ith symptoms or suffering trauma undergo MRI directly. Revision surgery is
pecific informed consent, based on EBM, allows patients to choose the best
jects undergo radiological follow-up every 6 months (earlier if the clinical picture
out the pros and cons of surgery. EBM = evidence-based medicine, MRI =
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our study, rupture was confirmed during revision surgery in 91%
of the cases where suspected extracapsular rupture was
diagnosed.
In these cases US of the breast is the appropriate diagnostic
procedure and there is no need to carry outMRI. From amedico-
legal point of view, timely surgery is justified by the fact that a
conservative approach or delayed surgery may expose the patient
to an increasing risk of complications due to the rupture. Delayed
surgery may mean that the operation becomes more complicated,
with a far less certain outcome. Delays, therefore, could result in
demands for increased damages: the disparity between the
expected results of prompt surgery and those obtained from
delayed surgery, involving aesthetic complications, may result in
claims for malpractice. [7–10,17–19]
Suspected intracapsular rupture diagnosed by US but not
confirmed by MRI normally occurs in patients who undergo
normal follow-up checks when the radiologist suspects, on the
basis of ultrasound, that the prosthesis is ruptured. These patients
normally are asymptomatic. From a clinical point of view, when
the prosthesis is ruptured but the pathology is only progressing
slowly, there is little expectation that the symptoms will worsen
during the follow-up period. As Holmich et al suggested, implant
rupture is a harmless event that does not seem to produce
significant clinical symptoms or activate the humoral immune
system. During the first 2 years following initial surgery there are
very few cases of severe localized problems and/or rupture, which
rather calls into question the belief that asymptomatic women
should undergo explantation surgery.[14] They proposed that
women with asymptomatic implant rupture should have regular
clinical check-ups, in order to assess any specific signs of free
silicone migration, although there appears to be only a slight risk
of this occurring.[14] While it is essential to perform revision
surgery when there is a definite diagnosis of implant rupture
because of the high risk of complications, in cases of suspected
rupture surgery can be delayed because of the low probability of
complications during the follow-up phase. Moreover, from the
surgical point of view, in case of intracapsular prosthetic no
systemic or local risks rupture is possible if surgery is
postponed.[4] An early operation, on the other hand, especially
on the basis of mere suspicion unsupported by clinical data,
unnecessarily exposes a patient with an intact prosthesis to the
risks inherent in surgery. It is preferable to give patients all
necessary information regarding their clinical condition, and to
explain that follow-up involving clinical-radiological monitoring
means fewer potential complications. It is also important for
patients with suspected ruptured implants to be informed that in
case of complications may be attributable to the spread of free
silicone (i.e., acute symptoms such as lumps, redness, soreness, or
swelling), gradual silicone seepage may cause or exacerbate
capsular contracture and the development of silicone granulo-
mas. Such complications should be investigated by ultrasound
scan and if this reveals a rupture, revision surgery will have to be
carried out as a matter of the highest priority. [7–10,17–19]
On the other hand, surgery is indicated if intracapsular rupture
is diagnosed by US and confirmed byMRI because of the real risk
that the clinical picture will deteriorate; however, since the risk of
complications is low, especially when compared with cases of
extracapsular rupture, the operation is not high priority.[7–10,17–
19] Unless there are complications or changes in the clinical
picture, surgery can safely be performed within 90 days.5
The emotional state of women diagnosed with a “suspected
implant rupture” during a normal follow-up check (inmost cases,
therefore, asymptomatic) should not be underestimated as this
can influence the diagnosis and, therefore, the subsequent
therapeutic procedure.
It is mandatory to inform patients about the importance of a
psychological counselling in such cases. If a patient whose
symptoms are psychosomatic refuses psychological support,
severe psychological discomfort may in itself be a sufficient
indication for surgery, since it is the duty of the physician to
protect both the physical and psychological health of the patient.
Therefore, should the patient continue to insist on undergoing
revision surgery, surgical intervention would be justified for the
psycho-physical protection of the patient’s health. From a
medico-legal point of view, it is necessary in such cases to
highlight the potential complications of reoperating, so that the
patient is fully aware of the risks of a negative outcome following
surgery, especially in those cases where the prosthesis is intact.
Before surgery it is essential to conduct a psychological
interview, in order to ascertain the capacity of the patient to give
consent and thereby avoid possible future disputes regarding the
validity of consent granted by patient in a fragile psychological
state.
In symptomatic patients with suspected intracapsular rupture
diagnosed by US andMRI, detailed information must be given to
the patient, including a description of the risks/benefits of the
operation and the follow-up. If the patient continues to express a
desire to undergo surgery, an intervention may be justified due to
the presence of symptoms and because of the need to safeguard
the woman’s physical and psychological wellbeing. [7–10,17]
A wide-ranging and exhaustive interview with the patient, to
be done in all the above scenarios described, is of primary
importance to be sure that her decision-making is founded on
evidence-based medicine and medical research and that best
practice will be applied: before giving her informed consent the
patient must receive a guarantee that no unnecessary surgical
treatment will be carried out.[4,7–10,17–19]
On the basis of our observational data we identified 5 possible
scenarios and described related suggested procedures (see
Supplementary Material – Annex 1, http://links.lww.com/MD/
E519).
4.1. Limitations of the Study
This study has some limitations to be pointed out:1. clinical and, especially, radiological evaluations must always
be regarded as highly physician-dependent.2. radiological diagnosis was not evaluated by a second
independent radiologist (as a second look procedure) before
starting surgical removal of the prosthesis; this procedure is
not mandatory in our Country.3. Generally textured implants have a slightly higher failure rate
than smooth-walled implants. The process of texturizing is
somewhat traumatic and is thought to play a role in the
increased leakage rate of the implant. However, the aim of our
study was not to research possible correlations between the
surface texturing and the prosthetic ruptures or to investigate
the frequency of rupture in cases of different prosthetic brands;
the aim of our study was to ensure the appropriate
management of cases of suspected prosthetic rupture and
reduce the risk of claims for medical malpractice.
Zingaretti et al. Medicine (2020) 99:27 Medicine4. All the removed prostheses were authorized and licensed by
European Community laws, although some of them were not
FDA licensed for material, texture, and labeling recommen-
dations.[23]
5. Conclusion
Our experience, according to up-to-date clinical evidences,
enabled us to highlight the inherent diagnostic and operative
difficulties in cases of suspected breast implant rupture, due to the
lack of standard published guidelines. We identified adequate
investigative procedures to be applied to cases of breast implant
rupture and a workable operative protocol which ensure the best
outcome for patients and prevent the risk of legal claims for
medical malpractice.
Further research is needed to confirm the utility of our
proposed protocol for better management of suspected breast
implant ruptures and reduce the risk of claims for compensation
from patients for unsatisfactory aesthetic outcomes or for the
unnecessary removal of a prosthesis.
A prospective study enrolling a larger number of patients will
be necessary to validate this protocol and assess its long-term
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